Literature DB >> 12672861

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.

Soju Chang1, Dawn M Sievert, Jeffrey C Hageman, Matthew L Boulton, Fred C Tenover, Frances Pouch Downes, Sandip Shah, James T Rudrik, Guy R Pupp, William J Brown, Denise Cardo, Scott K Fridkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12672861     DOI： 10.1056/NEJMoa025025

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  297 in total

1.  In vitro activities of daptomycin-, vancomycin-, and teicoplanin-loaded polymethylmethacrylate against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate strains of Staphylococcus aureus.

Authors:  Yuhan Chang; Wen-Chien Chen; Pang-Hsin Hsieh; Dave W Chen; Mel S Lee; Hsin-Nung Shih; Steve W N Ueng
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood.

Authors:  Christof von Eiff; John F Kokai-Kun; Karsten Becker; Georg Peters
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

3.  Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures.

Authors:  Melissa B Miller; Sonia L Allen; Mary Ellen Mangum; Anastassia Doutova; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 4.  Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.

Authors:  Catherine Liu; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II.

Authors:  Isabelle Verdier; Marie-Elisabeth Reverdy; Jerome Etienne; Gérard Lina; Michèle Bes; François Vandenesch
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

6.  Foot Infections in Diabetic Patients.

Authors:  James S Tan
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

7.  Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center in north India.

Authors:  Tuhina Banerjee; Shampa Anupurba
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

8.  Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans.

Authors:  Clayton Harro; Robert Betts; Walter Orenstein; Eun-Jeong Kwak; Howard E Greenberg; Matthew T Onorato; Jon Hartzel; Joy Lipka; Mark J DiNubile; Nicholas Kartsonis
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

9.  Nitric oxide nanoparticle technology: a novel antimicrobial agent in the context of current treatment of skin and soft tissue infection.

Authors:  Laura Englander; Adam Friedman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

10.  Large-scale identification of genes required for full virulence of Staphylococcus aureus.

Authors:  Bret M Benton; J P Zhang; Skip Bond; Casey Pope; Todd Christian; Lawrence Lee; Kelly M Winterberg; Molly B Schmid; Jerry M Buysse
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.